Search results
Order by most recent / most popular / relevance
Results: 1-10 of 22
Celgene Corporation v Canada (AG) - Supreme Court of Canada grants leave to appeal
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- May 21 2010
The Supreme Court of Canada has granted Celgene Corporation's application for leave to appeal the decision of a majority of the Federal Court of Appeal regarding the jurisdiction of the Patented Medicine Prices Review Board
First PMPRB decision dismissing allegations of excessive pricing
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- April 20 2010
The Patented Medicine Prices Review Board ("PMPRB") recently released its decision in the matter of Hoechst Marion Roussel Canada Inc. and the medicine NIOCODERM, a nicotine patch which assists those who are attempting to quit smoking; it is to be publicly posted on the PMPRB website today
The European Commission continues to examine settlement agreements and generic entry in the pharmaceutical sector
- Gowling Lafleur Henderson LLP
- -
- European Union
- -
- February 12 2010
The European Commission continues to scrutinize the pharmaceutical sector and patent settlement agreements between innovator and generic pharmaceutical companies
PMPRB guidelines and reporting requirements in effect for 2010
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- January 22 2010
The Patented Medicine Prices Review Board (PMPRB) released new Guidelines in 2009, including the new pricing tests the Board will apply for patented medicines
Canada (Attorney General) v. Celgene Corporation, appeal of a PMPRB decision
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- January 20 2010
The Court of Appeal overturned the decision of the Trial Judge and restored the decision of the PMPRB providing jurisdiction to the PMPRB over medicines imported under the Special Access Program
Court overturns PMPRB's decisions in respect of the medicine copaxone
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- November 18 2009
On November 12, 2009, Justice Hughes of the Federal Court allowed two judicial review applications of Teva Neuroscience G.P.-S.E.N.C. in respect of two decisions made by the Patented Medicine Prices Review Board
PMPRB issues first notices of hearing into prices of generic drugs
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- August 1 2008
In July 2008, the Patented Medicine Prices Review Board (PMPRB) announced that it has issued two Notices of Hearing with respect to the prices of generic drugs sold in Canada by Apotex Inc. and ratiopharm Inc
PMPRB issues Notice of Hearing - Apotex Inc
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- April 21 2008
The Patented Medicine Prices Review Board (PMPRB) has issued a Notice of Hearing into certain allegations against Apotex Inc
PMPRB departs from its guidelines in determining price in recent decision
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- April 21 2008
In a significant decision dated April 10, 2008, a Hearing Panel of the Patented Medicine Prices Review Board (PMPRB) has ruled that it is not appropriate to apply the PMPRB's Excessive Price Guidelines to assess the pricing of once-daily drugs used to treat attention deficit hyperactivity disorder (ADHD
In a new decision, the PMPRB identifies "exceptional" circumstances when a patentee may increase prices in excess of its guidelines
- Gowling Lafleur Henderson LLP
- -
- Canada
- -
- March 6 2008
In a decision made public on March 4, 2008, the Patented Medicine Prices Review Board (PMPRB) has found that a price increase greater than the annual increase in the CPI is not excessive
Current Search
- Workarea - Intellectual Property
- Workarea - Competition
- Firm Name - Gowling Lafleur Henderson LLP